Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2011-03-15
2011-03-15
Zara, Jane (Department: 1635)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S091100, C435S091310, C435S458000, C536S023100
Reexamination Certificate
active
07906641
ABSTRACT:
The invention provides a group of nucleic acid fragments, shown in the sequence listing, for prevention of HIV infection or AIDS and the usage thereof. In the invention, a series of RNA fragments, which are highly homogenous to all the published HIV gene sequences, were obtained by homology compare. The double-stranded RNA (dsRNA) derived from these fragments can effectively inhibit the expression of the HIV genes. The RNA transcribed by plasmid, also can suppress the expression of the HIV in the cell. After the adenovirus or associated virus which carry DNA corresponding above RNA infect the cell, the transcription dsRNA can inhibit the expression of the HIV genes.
REFERENCES:
patent: 5958768 (1999-09-01), Kraus et al.
patent: 5965726 (1999-10-01), Pavlakis et al.
patent: 6503705 (2003-01-01), Kozal et al.
patent: 6506559 (2003-01-01), Fire et al.
patent: 7129041 (2006-10-01), Merigan et al.
patent: 2002/0031521 (2002-03-01), Spetz-Holmgren et al.
patent: 2003/0175950 (2003-09-01), McSwiggen
patent: 2006-502694 (2006-01-01), None
patent: WO 02/44321 (2002-06-01), None
patent: 03/070193 (2003-08-01), None
Schwarz, D.S. et al., Cell, vol. 115, pp. 199-208 (2003).
Peracchi, A. et al., Rev. Med Virol., vol. 14, pp. 47-64 (2004).
Chirila, T. et al., Biomaterials, vol. 23, pp. 321-324 (2002).
Agrawal, S. et al., Molecular Med. Today, vol. 6, pp. 72-81 (2000).
Crooke, S., Annu. Rev. Med., vol. 55, pp. 61-95 (2004).
Opalinska, J.B., et al., Nature Reviews, vol. 1, pp. 503-514 (2002).
Branch, A., Trends in Biochem. Sci., vol. 23, pp. 45-50 (1998).
European Office Action dated Feb. 19, 2008, in European Patent Application No. 03782054.5.
Takuya Yamamoto et al., “Double-StrandednefRNA Interferes with Human Immunodeficiency Virus Type 1 Replication”, Microbiol. Immunol., 2002, 46(11): 809-817.
Wee-Sung Park et al., “Prevention of HIV-1 infection in human peripheral blood mononuclear cells by specific RNA interference”, Nucleic Acids Research, 2002, 30(22): 4830-4835.
Jean-Marc Jacque et al., “Modulation of HIV-1 replication by RNA interference”, Nature, 2002, 418: 435-438.
Carl D. Novina et al., “siRNA-directed inhibition of HIV-1 infection”, Nature Medicine, 2002, 8(7): 681-686.
John Capodici et al., “Inhibition of HIV-1 Infection by Small Interfering RNA-Mediated RNA Interference”, The Journal of Immunology, 2002, 169: 5196-5201.
Glen A. Coburn et al., “Potent and Specific Inhibition of Human Immunodeficiency Virus Type 1 Replication by RNA Interference”, The Journal of Virology, 2002, 76(18): 9225-9231.
Nan Sook Lee et al., “Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells”, Nature Biotechnology, 2002, 20: 500-505.
Japanese Office Action dated Feb. 17, 2009, in Japanese Patent Application No. 2004-559574.
Office Action issued in corresponding European Patent Application No. 03782054.5 on Apr. 22, 2010 (in the name of Beijing Joinn Pharmaceutical Center).
Feng Yuxia
Li Yuejuan
Zhou Zhiwen
Zuo Conglin
Beijing Solobio Genetechnology Company Ltd.
Sughrue & Mion, PLLC
Zara Jane
LandOfFree
Group of nucleic acid fragments for prevention of HIV... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Group of nucleic acid fragments for prevention of HIV..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Group of nucleic acid fragments for prevention of HIV... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2663794